Sangamo BioSciences, Inc. (SGMO) Reports Third Quarter 2009 Financial Results
11/5/2009 9:12:36 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at Merriman Curhan Ford & Co.'s Investor Summit 2009
11/4/2009 8:41:32 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Third Quarter 2009 Conference Call and Webcast
10/29/2009 8:30:45 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting Improvement in Intraepidermal Nerve Fiber Density Demonstrates Neuroregenerative Mechanistic Proof of Concept
10/21/2009 8:26:40 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Closing of Common Stock Offering
10/13/2009 10:49:48 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Pricing of Public Offering of Common Stock
10/7/2009 8:41:57 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) (JOBS) Lands $20 Million in Expanded Sigma-Aldrich Corporation (SIAL) Deal
10/5/2009 6:29:03 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Research Collaboration With University of California, Los Angeles (UCLA) in Human Stem Cells Selected to Receive Clinical Research Award
10/1/2009 10:17:13 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at the JMP Securities Healthcare Conference
9/29/2009 9:24:39 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at the UBS Global Life Sciences Conference
9/17/2009 10:49:29 AM
More...
|
|